Longeveron (LGVN) to Release Quarterly Earnings on Wednesday

Longeveron (NASDAQ:LGVN) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, August 13th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $0.41 million for the quarter.

Longeveron Stock Up 2.6%

Shares of Longeveron stock opened at $0.70 on Tuesday. The stock’s fifty day moving average is $1.38 and its two-hundred day moving average is $1.47. The company has a market capitalization of $10.55 million, a PE ratio of -0.11 and a beta of 0.23. Longeveron has a 52 week low of $0.63 and a 52 week high of $2.86.

Longeveron Company Profile

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company’s lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors.